| Stem definition | Drug id | CAS RN |
|---|---|---|
| sympathomimetics | 2305 | 101-40-6 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
None
None
None
None
None
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.29 | Basic |
None
None
None
| ID | Source |
|---|---|
| 4033392 | VUID |
| N0000190761 | NUI |
| D05637 | KEGG_DRUG |
| 4033392 | VANDF |
| C0033508 | UMLSCUI |
| CHEBI:134783 | CHEBI |
| CHEMBL2105275 | ChEMBL_ID |
| DB06714 | DRUGBANK_ID |
| 7558 | PUBCHEM_CID |
| 566 | INN_ID |
| C084814 | MESH_SUPPLEMENTAL_RECORD_UI |
| LQU92IU8LL | UNII |
| 227666 | RXNORM |
| 11906 | MMSL |
| 7550 | MMSL |
| 001805 | NDDF |
| 398882009 | SNOMEDCT_US |
| 51321007 | SNOMEDCT_US |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| BENZEDREX09-19-2014 | HUMAN OTC DRUG LABEL | 1 | 0225-0610 | INHALANT | 250 mg | NASAL | OTC monograph final | 13 sections |
| BENZEDREX09-19-2014 | HUMAN OTC DRUG LABEL | 1 | 0225-0610 | INHALANT | 250 mg | NASAL | OTC monograph final | 13 sections |
| BENZEDREX09-19-2014 | HUMAN OTC DRUG LABEL | 1 | 0225-0610 | INHALANT | 250 mg | NASAL | OTC monograph final | 13 sections |
| BENZEDREX | HUMAN OTC DRUG LABEL | 1 | 0225-0611 | INHALANT | 175 mg | NASAL | OTC monograph final | 13 sections |